(Q36690273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

review article

1 reference

title

Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Bruno Quesnel

series ordinal

1

1 reference

15 August 2017

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

773-781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

Dormancy in a model of murine B cell lymphoma

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Are tumours angiogenesis-dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Mathematical models of cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Cancer dormancy: isolation and characterization of dormant lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

T-cell immunity in the induction and maintenance of a tumour dormant state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

The balance of immune responses: costimulation verse coinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

B7-H1 pathway and its role in the evasion of tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Applying the principles of stem-cell biology to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

A tumorigenic subpopulation with stem cell properties in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Melanoma, a tumor based on a mutant stem cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Identification of bronchioalveolar stem cells in normal lung and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Rehabilitation of cancer through oncogene inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

NK cells: innate immunity against hematological malignancies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.6.773

Novel APC-like properties of human NK cells directly regulate T cell activation

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI22787

Identifiers

DOI

10.1586/14760584.5.6.773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184216%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference